UTMD Utah Medical: רווח למניה ב-12 החודשים האחרונים

The Utah Medical Products (UTMD) EPS (TTM) chart on the GURU.Markets platform stands at -5.50, illustrating the success of its niche production of high-margin products for women's health and neonatology. The business relies on plants in the US, UK, and Ireland to ensure logistical stability. The current stage of development involves expanding the specialized portfolio while strictly monitoring expenses to maintain exceptional operating profit.
פילוחי מדדים פיננסיים ומדדי שוק עבור Utah Med (UTMD)

An objective assessment of the investment attractiveness of Utah Medical Products requires a deep fundamental analysis of profit dynamics. This metric measures the percentage change in net income per share over the last twelve months relative to the previous year. By analyzing the year-over-year change in EPS (TTM), an investor separates market noise from real business growth. The stability of this indicator confirms the high operational efficiency of the company's specialized medical device manufacturing in the US and Ireland.